• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有更严重 IBD 的患者会感染艰难梭菌,而不是艰难梭菌会增加 IBD 的严重程度。

Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.

机构信息

Department of Medicine, New York Presbyterian Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA.

Division of Digestive and Liver Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY, 10032, USA.

出版信息

Dig Dis Sci. 2021 Sep;66(9):3113-3123. doi: 10.1007/s10620-020-06504-y. Epub 2020 Jul 29.

DOI:10.1007/s10620-020-06504-y
PMID:32729015
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) patients who have Clostridioides difficile infection (CDI) have worse outcomes.

AIMS

We aimed to determine whether such outcomes are the result of CDI or whether CDI occurs in patients who have more severe IBD.

METHODS

This was a retrospective study of patients hospitalized for ≥ 2 IBD flares from 2010 to 2019. The primary outcome was time to IBD flare between hospitalizations. First, time to flare was compared between patients who were hospitalized for a flare complicated by CDI and subsequently for a CDI-negative flare (cohort A, denoted +/-) versus patients who were hospitalized for two CDI-negative flares (cohort B, -/-). Second, time between flares was compared within the subset of cohort A patients who had three flares (cohort C, -/+/-) before and after CDI.

RESULTS

Time between flares was a median of 4 months (IQR 1-9) among 51 cohort A patients versus 12 months (IQR 6-38) among 51 cohort B patients (log-rank P < 0.01). In contrast, the median time between flares was similar within cohort C before and after CDI (log-rank P = 0.54). At time of the second IBD flare, patients in cohort A (+/-) were more likely to have moderate or severe disease compared to patients in cohort B (-/-).

CONCLUSIONS

Patients with prior CDI had shorter time to subsequent IBD flare relative to their CDI-negative counterparts. This is not likely due to CDI itself because there was no difference in time between flares before versus after acquiring CDI. Rather, patients who acquire CDI may have more severe IBD.

摘要

背景

患有艰难梭菌感染(CDI)的炎症性肠病(IBD)患者预后更差。

目的

我们旨在确定这些结果是由 CDI 引起的,还是 CDI 发生在病情更严重的 IBD 患者中。

方法

这是一项回顾性研究,纳入了 2010 年至 2019 年期间因≥2 次 IBD 发作而住院的患者。主要结局是两次住院之间 IBD 发作的时间。首先,将因 CDI 并发的 IBD 发作而住院随后因 CDI 阴性发作(队列 A,记为 +/-)的患者与因两次 CDI 阴性发作(队列 B,-/-)的患者的发作时间进行比较。其次,在队列 A 中,比较了在 CDI 之前和之后有三次发作(队列 C,-/+/-)的患者的发作之间的时间。

结果

51 例队列 A 患者的两次发作之间的时间中位数为 4 个月(IQR 1-9),51 例队列 B 患者的两次发作之间的时间中位数为 12 个月(IQR 6-38)(对数秩 P < 0.01)。相比之下,在 CDI 前后,队列 C 内的两次发作之间的时间中位数相似(对数秩 P = 0.54)。在第二次 IBD 发作时,与队列 B 患者(-/-)相比,队列 A( +/-)患者更可能患有中度或重度疾病。

结论

与 CDI 阴性对照相比,先前患有 CDI 的患者发生后续 IBD 发作的时间更短。这可能不是由于 CDI 本身引起的,因为在获得 CDI 之前和之后,发作之间的时间没有差异。相反,患有 CDI 的患者可能患有更严重的 IBD。

相似文献

1
Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.患有更严重 IBD 的患者会感染艰难梭菌,而不是艰难梭菌会增加 IBD 的严重程度。
Dig Dis Sci. 2021 Sep;66(9):3113-3123. doi: 10.1007/s10620-020-06504-y. Epub 2020 Jul 29.
2
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.炎症性肠病发作时的肠道感染影响两年后的结局。
Inflamm Bowel Dis. 2024 Oct 3;30(10):1759-1766. doi: 10.1093/ibd/izad253.
3
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.炎症性肠病住院患者中艰难梭菌感染的相关近期趋势和危险因素。
Aliment Pharmacol Ther. 2024 Jan;59(1):89-99. doi: 10.1111/apt.17777. Epub 2023 Oct 24.
4
Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.粪便微生物移植治疗炎症性肠病中复发性艰难梭菌感染的疗效。
Inflamm Bowel Dis. 2020 Aug 20;26(9):1415-1420. doi: 10.1093/ibd/izz299.
5
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.艰难梭菌与炎症性肠病:在发病机制中的作用及其在治疗中的意义。
World J Gastroenterol. 2013 Nov 21;19(43):7577-85. doi: 10.3748/wjg.v19.i43.7577.
6
Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.炎症性肠病患者与非炎症性肠病人群中艰难梭菌相关性腹泻的临床结局:一项回顾性队列研究。
Medicine (Baltimore). 2023 Feb 10;102(6):e32812. doi: 10.1097/MD.0000000000032812.
7
Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.高风险老年人群中艰难梭菌的粪便微生物移植与早期复发相关。
Dig Dis Sci. 2020 Dec;65(12):3647-3651. doi: 10.1007/s10620-020-06147-z. Epub 2020 Feb 20.
8
Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.艰难梭菌感染的诊断方式可预测炎症性肠病的治疗反应和结局。
Dig Dis Sci. 2021 Feb;66(2):547-553. doi: 10.1007/s10620-020-06205-6. Epub 2020 Mar 23.
9
[ Infection in Patients with Inflammatory Bowel Disease].[炎症性肠病患者的感染]
Korean J Gastroenterol. 2022 Aug 25;80(2):66-71. doi: 10.4166/kjg.2022.097.
10
Prevalence and Risk Factors of Clostridium difficile Infection Among Patients Hospitalized for a Flare of Inflammatory Bowel Disease in King Abdulaziz University Hospital.阿卜杜勒阿齐兹国王大学医院炎症性肠病发作住院患者艰难梭菌感染的患病率及危险因素
Cureus. 2023 Nov 7;15(11):e48451. doi: 10.7759/cureus.48451. eCollection 2023 Nov.

引用本文的文献

1
Global Patterns of Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors.炎症性肠病患者的全球感染模式:患病率、流行病学和危险因素的系统评价与荟萃分析
Crohns Colitis 360. 2025 Mar 27;7(2):otaf024. doi: 10.1093/crocol/otaf024. eCollection 2025 Apr.
2
Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.内脏脂肪含量独立预测炎症性肠病的发作时间,但体重指数则不能。
Inflamm Bowel Dis. 2024 Apr 3;30(4):594-601. doi: 10.1093/ibd/izad111.
3
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.

本文引用的文献

1
Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.溃疡性结肠炎合并艰难梭菌感染患者的临床结局。
Dig Dis Sci. 2010 Feb;55(2):415-20. doi: 10.1007/s10620-009-0749-9. Epub 2009 Mar 3.
质子泵抑制剂与炎症性肠病肠道感染的风险:一项自身对照病例系列研究。
Inflamm Bowel Dis. 2024 Jan 5;30(1):38-44. doi: 10.1093/ibd/izad035.
4
Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease.宿主山梨糖醇和细菌山梨糖醇利用促进炎症性肠病中的艰难梭菌感染。
Gastroenterology. 2023 Jun;164(7):1189-1201.e13. doi: 10.1053/j.gastro.2023.02.046. Epub 2023 Mar 8.
5
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.肠道炎症和肠道微生物群改变与炎症性肠病相关,使小鼠易感染艰难梭菌定植和感染。
mBio. 2021 Jun 29;12(3):e0273320. doi: 10.1128/mBio.02733-20. Epub 2021 Jun 15.
6
How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?艰难梭菌感染如何加重炎症性肠病:是艰难梭菌感染(CDI)还是临床严重程度指数(CDAI)?
Dig Dis Sci. 2021 Sep;66(9):2849-2850. doi: 10.1007/s10620-020-06667-8. Epub 2020 Oct 23.